ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage

Zhou, Qing; Li, Peixin; Zhao, Hengli; Xu, Xingbo; Li, Shaoping; Zhao, Jing; Xu, Dingli*; Zeng, Qingchun*南方医科大学
Frontiers in Cardiovascular Medicine2021-5-25DOI: 10.3389/fcvm.2021.678121
7被引6阅读
引用收藏
分享

摘要

Heart failure with mid-range ejection fraction (HFmrEF) was first proposed by Lam and Solomon in 2014, and was listed as a new subtype of heart failure (HF) in 2016 European Society of Cardiology guidelines. Since then, HFmrEF has attracted an increasing amount of attention, and the number of related studies on this topic has grown rapidly. The diagnostic criteria on the basis of left ventricular ejection fraction (LVEF) are straightforward; however, LVEF is not a static parameter, and it changes dynamically during the course of HF. Thus, HFmrEF may not be an independent disease with a uniform pathophysiological process, but rather a collection of patients with different characteristics. HFmrEF is often associated with various cardiovascular and non-cardiovascular diseases. Thus, the pathophysiological mechanisms of HFmrEF are particularly complex, and its clinical phenotypes are diverse. The complexity and heterogeneity of HFmrEF may be one reason for inconsistent results between clinical studies. In fact, whether HFmrEF is a distinctive subtype or a transitional stage between HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF) is controversial. In this review, we discuss the clinical characteristics, treatment and prognosis of patients with HFmrEF, as well as the differences among HFmrEF, HFrEF, and HFpEF.

学科与关键词

关键词
heart failuremid-range ejection fractionpreserved ejection fractionangiotensin receptor-neprilysin inhibitorssodium-glucose co-transporter 2 inhibitors
相关
加载中…
  • Similarities and Differences Between HFmrEF and HFpEF
    Li, Peixin; Zhao, Hengli; Zhang, Jianyu; Ning, Yunshan; Tu, Yan; Xu, Dingli*; Zeng, Qingchun*Frontiers in Cardiovascular Medicine, 2021, 8: 678614.被引 14
  • Research based on the core pathogenesis in the treatment according to traditional Chinese medicine syndrome differentiation for heart failure with normal ejection fraction
    Zhiqiang, Zhao; Xianliang, Wang; Shuai, Wang; Ruijuan, Zhou; Quan, Su; Yu, Liu; Tao, Cheng; Qing, Li; Shanshan, Lin; Hua, Liu; Jingyuan, MaoMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2020, 99(37): e21663.
  • Sex-specific characteristics and outcomes in hospitalized heart failure with preserved ejection fraction: the China Cardiovascular Association Database-Heart Failure Center Registry
    Cai, Anping; Qiu, Weida; Xia, Shuang; Zhou, Yingling; Chen, Jiyan; Tan, Ning; Gao, Zhiping; Ou, Yanqiu; Li, Weimin; Liao, Yuhua; Dong, Yugang; Li, Xinli; Zhou, Jingmin; Feng, Yingqing*; Li, Liwen*; Yang, Jiefu*European Heart Journal, 2023, 44(44): 4715-4718.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cardiovascular Medicine
发表日期
2021-05-25
卷期
第 8 卷
页码
678121
DOI
10.3389/fcvm.2021.678121
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Science and Technology Program of Guangzhou [201804010086, 201707020012, 82070403, 81770386]; Frontier Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110105001]; Youth Science and Technology Innovation Talent of Guangdong TeZhi Plan [2019TQ05Y136]

作者

  • Z

    Zhou, Qing (第一作者)

    southern med univ · hubei univ arts & sci

  • L

    Li, Peixin

    southern med univ

查看全部 8 位作者收起作者
  • Z

    Zhao, Hengli

    southern med univ

  • X

    Xu, Xingbo

  • L

    Li, Shaoping

  • Z

    Zhao, Jing

  • X

    Xu, Dingli (通讯)

    southern med univ

  • Z

    Zeng, Qingchun (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417